| Dr Aaron Charles Jannings, MD | |
|
9300 Dewitt Loop, Fort Belvoir, VA 22060-5285 | |
| (571) 231-3224 | |
| Not Available |
| Full Name | Dr Aaron Charles Jannings |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 9300 Dewitt Loop, Fort Belvoir, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043668452 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 30298 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aaron Charles Jannings, MD 9300 Dewitt Loop, Fort Belvoir, VA 22060-5285 Ph: (571) 231-3224 | Dr Aaron Charles Jannings, MD 9300 Dewitt Loop, Fort Belvoir, VA 22060-5285 Ph: (571) 231-3224 |
News Archive
When two adjacent discs in the low back wear out, become compressed and cause unmanageable pain, numbness or other symptoms, replacement with artificial discs can be a viable alternative to standard fusion surgery, based on two-year post-surgery data from a randomized, multicenter trial recently published in the Journal of Bone and Joint Surgery.
In a study published in Nature Genetics today, a team of scientists at The Institute of Cancer Research have discovered a gene that may hold clues to the development of many cases of the most common cancers including lung, breast, prostate and colon cancers.
Huntington's disease is a genetic disorder that affects movement, thinking, and some aspects of personality. There is no treatment or cure for the disease.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that the U. S. Patent and Trademark Office has issued two patents covering the company's lead drug candidate and related compounds. One patent, US number 7,728,117, specifically covers GMI-1070, the Company's drug candidate now in clinical trials of patients with vaso-occlusive crisis of sickle cell disease. The second patent, US number 7,741,312, contains claims covering a family of molecules that includes and extends beyond GMI-1070.
Palbociclib, a new oral drug whose efficacy in combating breast cancer has been demonstrated alone and in combination with endocrine therapy, also has potential to combat other types of cancer, according to a literature review and additional original research conducted by experts at the Abramson Cancer Center in the University of Pennsylvania published this month in JAMA Oncology.
› Verified 9 days ago
Dr. Matthew R Noss, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 9501 Farrell Rd, Fort Belvoir, VA 22060 Phone: 703-805-0146 | |
Nicole Deren, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 760-719-3675 | |
Dr. Margaret Elyse Santucci, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 571-231-2664 | |
Dr. Kelly G Koren, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 571-231-3224 | |
Dr. Caitlyn De Kanter, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 571-231-1803 | |
Dr. Zachary Daniel Mcrae, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 571-231-3224 |